Document Type : Research Paper
Authors
Abstract
In this work, the effective factors on the preparation of 67Ga-oxinate complex for white blood cell labeling were determined. Gallium-67 was produced at AMIRS 30MeV cyclotron via 68Zn(p,2n)67Ga reaction in the from of 67GaCl3, and was used for radiolabeling of oxinate complex at optimized conditions. A mixture of 67GaCl3 (3uL, 200uCi) and ethanolic oxine solution (1mg/ml, 100μl) was evaporated and reacted at 25ºC for 1 h in the presence of NaOAc solution (pH. 5.5). ITLC was performed using a mixture of ammonium actetae and methanol solution (1:1) followed by recording the activity using radio thin layer chromatography scanner. The radiochemical purity of %95.18 at these conditions was obtained (specific activity of 1432 GBq/mmol). Freshly prepared white blood cells were separated from human volunteers and used for labeling by the above mentioned complex at 37ºC. 67Ga-oxinate complex due to it’s lipophilicity and suitable gamma rays is a suitable cell labeling agent and available for blood stem cell and microorganism studies.
Highlights
- 1. C. Bekerman, P.B. Hoffer, J.D. Bitran, “The rules of gallium-67 in the clinical evaluation of cancer,” Semin. Nucl. Med. 14, 296-323 (1984).
- 2. J. Ruhlmann, P. Oehr, H.J. Biersach, “Cost effectiveness of PET in oncology,” 195-97 in: PET in oncology Ist edition Springer-Verlage Press, New York (1999).
- 3. C.M. Lederer, V.S. Shirly, “Table of Isotopes,” 7th Edition. 211, John Willy and Sons Press. New York (1978).
- 4. A.R. Jalilian, P. Rowshanfarzad, M. Sabet, A. Rahiminejad-Kisomi A.A. Rajamand, “Development of [66Ga]oxine complex; a possible PET tracer,” Nukleonika 51, 155-159 (2006).
- 5. L. Kostakoglow, J. Leonardo, I. Kujh, “Comparision of fluorine -18 fluorodeoxy glucose positron emission tomography and Ga-67 scintigraphy in evalution of lumphoma,” Cancer 94, 879-888 (2002).
- 6. http://www.ambion.com/techilb/append/supp/wbc/html.
Keywords
- 1. C. Bekerman, P.B. Hoffer, J.D. Bitran, “The rules of gallium-67 in the clinical evaluation of cancer,” Semin. Nucl. Med. 14, 296-323 (1984).
- 2. J. Ruhlmann, P. Oehr, H.J. Biersach, “Cost effectiveness of PET in oncology,” 195-97 in: PET in oncology Ist edition Springer-Verlage Press, New York (1999).
- 3. C.M. Lederer, V.S. Shirly, “Table of Isotopes,” 7th Edition. 211, John Willy and Sons Press. New York (1978).
- 4. A.R. Jalilian, P. Rowshanfarzad, M. Sabet, A. Rahiminejad-Kisomi A.A. Rajamand, “Development of [66Ga]oxine complex; a possible PET tracer,” Nukleonika 51, 155-159 (2006).
- 5. L. Kostakoglow, J. Leonardo, I. Kujh, “Comparision of fluorine -18 fluorodeoxy glucose positron emission tomography and Ga-67 scintigraphy in evalution of lumphoma,” Cancer 94, 879-888 (2002).
- 6. http://www.ambion.com/techilb/append/supp/wbc/html.